Is the device tax the job killer it's made out to be?; Ventus rolls out sleep apnea device in Canada

 @FierceMedDev: Wright Medical plans to merge with BioMimetic in a $380M deal: orthopedics + regenerative medicine = the future. More | Follow @FierceMedDev

 @MarkHFierce: St. Jude gained a CE mark for its new transcatheter aortic heart valve/transfemoral delivery system. Watch out, Sapien? News | Follow @MarkHFierce

 @DamianFierce: Big week for CRO Chiromics, signing deals with GSK and Bristol-Myers. Story | Follow @DamianFierce

> Medical device companies have billed the impending 2.3% tax as a "job-killing raid," but will the charge really be that hard on revenues? Column

> Sparton ($SPA) has closed its $43.25 million acquisition of medical device manufacturer Onyx ($ONXX), a deal it says will add $50 million a year in revenue. More

> Ventus Medical has launched Provent, its sleep apnea-treating device, in Canada. Release

> Scientists at MIT have created a fiber-optic 3-D "light switch" that can deliver precise points of light to the brain, possibly finding use in treatments for Parkinson's disease and epilepsy. Item

> Next-generation robotic surgical devices are leaving even less of footprint than earlier models, The New York Times reports. Story (sub. req.)

> Vitacon, the Norwegian maker of an ultrasound bladder scanner ,is launching the product in the U.S. Story

> Oregon State electrical engineers concocted a new post stamp-sized medical monitoring device that could fit on a bandage and cost less than 25 cents. Release

Biotech News

 @FierceBiotech: From FierceBiotechIT.com: Cmed expanding in North Carolina as CRO-tech combos take off. Story | Follow @FierceBiotech

 @JohnCFierce: SR One, etc., provide $37.5M round for Applied Genetic Technologies. Working on gene therapies. News | Follow @JohnCFierce

 @RyanMFierce: Cmed expanding in North Carolina as CRO-tech combos take off. Report | Follow @RyanMFierce

> Troubled sequencing pioneer Helicos shelters in bankruptcy court. Story

> Road kill or takeover target? Amarin in limbo as it waits for key FDA decision. Report

> Booming Novo Nordisk shoots for top drugmaker status. Item

Pharma News

@FiercePharma: Pfizer CEO Ian Read ordered to testify in Chantix case. More | Follow @FiercePharma

> Novo Norkdisk, largest Nordic company, shoots for top drugmaker. Report

> Calpers, others, battle Pfizer separately on Bextra shareholder claims. News

> Illumina gets dose of its own medicine, spurned by Complete Gemomics. Item

Biotech IT News

> Merck backs Remedy Informatics with $6M investment. Report

> Roche engages patient groups in social media effort. Article

> Cmed expanding in North Carolina as CRO-tech combos take off. News

> Johnson & Johnson, Merck and Eli Lilly to rip red tape from clinical trials. Story

CRO News

> PPD gets high-tech for adaptive trials. Item

> Big Pharma supergroup plots clinical trial site database. Story

> Chiromics inks discovery deals with Bristol-Myers, GSK. Article

> Aptuit extends GSK partnership at Italian site. More

> WuXi ticks up income after strong Q3. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.